Frankfurt - Delayed Quote EUR
Atai Life Sciences N.V. (9VC.F)
1.3700
+0.1490
+(12.20%)
As of 5:08:32 PM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 16.78M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.40 per share. | Indirect | 2,520,000 | Mar 24, 2025 |
| RAO SRINIVAS Chief Executive Officer | Sale at price 1.35 per share. | Direct | 101,814 | Mar 21, 2025 |
| KIRPEKAR SAHIL Officer | Sale at price 1.35 per share. | Direct | 65,560 | Mar 21, 2025 |
| JOHNSON ANNE NAGENGAST Chief Financial Officer | Sale at price 1.35 per share. | Direct | 45,286 | Mar 21, 2025 |
| CRAIG KEVIN JAMES M.D. Officer | Sale at price 1.35 per share. | Direct | 15,610 | Mar 21, 2025 |
| SHORT GLENN FRANK PH.D. Officer | Sale at price 1.35 per share. | Direct | 17,767 | Mar 21, 2025 |
| RAO SRINIVAS Chief Executive Officer | -- | Direct | -- | Mar 14, 2025 |
| KIRPEKAR SAHIL Officer | -- | Direct | -- | Mar 14, 2025 |
| JOHNSON ANNE NAGENGAST Chief Financial Officer | -- | Direct | -- | Mar 14, 2025 |
| CRAIG KEVIN JAMES M.D. Officer | -- | Direct | -- | Mar 14, 2025 |
| SHORT GLENN FRANK PH.D. Officer | -- | Direct | -- | Mar 14, 2025 |
| APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.10 per share. | Indirect | 22,755,008 | Feb 14, 2025 |
| BRAND FLORIAN Chief Executive Officer | Sale at price 1.92 per share. | Direct | 290,502 | May 16, 2024 |
| RAO SRINIVAS Officer | Sale at price 1.85 per share. | Direct | 114,034 | Apr 2, 2024 |
| KIRPEKAR SAHIL Officer | Sale at price 1.85 per share. | Direct | 66,232 | Apr 2, 2024 |
| JOHNSON ANNE NAGENGAST Chief Financial Officer | Sale at price 1.85 per share. | Direct | 50,708 | Apr 2, 2024 |
| RAO SRINIVAS Officer | -- | Direct | -- | Mar 14, 2024 |
| BRAND FLORIAN Chief Executive Officer | -- | Direct | -- | Mar 14, 2024 |
| KIRPEKAR SAHIL Officer | -- | Direct | -- | Mar 14, 2024 |
| JOHNSON ANNE NAGENGAST Chief Financial Officer | -- | Direct | -- | Mar 14, 2024 |
| BRAND FLORIAN Chief Executive Officer | Purchase at price 1.16 per share. | Direct | 23,120 | Nov 16, 2023 |
| BRAND FLORIAN Chief Executive Officer | Purchase at price 1.45 per share. | Direct | 57,968 | Sep 13, 2023 |
Related Tickers
ADXN Addex Therapeutics Ltd
7.60
0.00%
ANL Adlai Nortye Ltd.
2.0500
+12.02%
9606.HK Duality Biotherapeutics, Inc.
218.600
-0.46%
VALN Valneva SE
7.00
+0.86%
GLPG Galapagos NV
25.38
+1.20%
GUBRA.CO Gubra A/S
361.20
+3.44%
AFMD Affimed N.V.
0.7638
+3.36%
ALMS Alumis Inc.
4.9800
+0.20%
REPL Replimune Group, Inc.
9.03
+3.67%
YMAB Y-mAbs Therapeutics, Inc.
4.1708
-2.09%